Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
We examined the association of three serum immune markers with CD4 cell counts in a large cohort of i.v. drug users with and without human immunodeficiency virus (HIV) infection. Levels of beta 2-microglobulin and neopterin were significantly elevated in HIV-infected subjects and increased in association with decline in CD4 cell counts (all p less than 0.001). Serum IgA levels in HIV-seropositive individuals were significantly elevated only when the CD4 cell count was less than 200/microliters (p less than 0.001). After controlling for HIV status and CD4 count, recent history of hepatitis was associated with significantly higher beta 2-microglobulin (p = 0.028) and marginally higher neopterin (p = 0.052) levels. There was no association of race, gender, or drug use patterns with levels of serum immune markers after controlling for HIV status and CD4 count. These data indicate that immune activation is coupled with immunosuppression in HIV-infected i.v. drug users. In addition, beta 2-microglobulin and neopterin levels are elevated in persons with a recent history of hepatitis but not in those with recent non-AIDS-defining bacterial infections. Markers of immune activation do not vary by race, gender, or drug use patterns among i.v. drug users.
Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
R E
RE
Chaisson
E
E
Taylor
J B
JB
Margolick
A
A
Muñoz
L
L
Solomon
S
S
Cohn
K E
KE
Nelson
D
D
Vlahov
D015415:Biomarkers / Q000097:blood*; D001708:Biopterins / Q000031:analogs & derivatives / Q000097:blood; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007958:Leukocyte Count; D008137:Longitudinal Studies; D008297:Male; D019798:Neopterin; D011446:Prospective Studies; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000453:epidemiology / Q000276:immunology*; D001613:beta 2-Microglobulin / Q000032:analysis
D015415:Biomarkers; D007070:Immunoglobulin A; D001613:beta 2-Microglobulin; D001708:Biopterins; D019798:Neopterin